| Round 1 | Round 2 | Crude OR | Adjusted OR^ | p-value |
---|---|---|---|---|---|
% N = 2032 | % N = 2006 | (95% CI) | (95% CI) | (Wald test) | |
HR-MSM | |||||
HIV-1 infection | 9.7 | 10.9 | 1.2 (0.7-1.9) | 1.1 (0.7-1.9) | 0.57 |
Reactive RPR + positive TPHA | 14.3 | 6.8 | 0.43 (0.3-0.7) | 0.37 (0.2-0.6) | <0.01 |
Reactive RPR >1:8 + positive TPHA | 3.63 | 3.43 | 0.94 (0.5-1.8) | 1.15 (0.6-2.35) | 0.68 |
Chlamydia infection | 0.68 | 0.51 | 0.74 (0.3-2.1) | 2.2 (.5-8.9) | 0.29 |
Gonorrhoea infection | 0.07 | 0.15 | 2.0 (0.2-18.3) | 6.9 (0.3-159.5) | 0.23 |
Chlamydia and/or gonorrhoea infection | 0.76 | 0.56 | 0.75 (0.3-2.2) | 2.3 (.6-9.4) | 0.24 |
HIV prevalence (district-wise) | Â | Â | Â | Â | Â |
Chennai | 4.8 | 10.9 | 2.5 (1.1-5.2) | 2.6 (0.97-6.8) | 0.06 |
Coimbatore | 6.5 | 11.2 | 1.8 (0.94-3.5) | 2.2 (0.97-5.0) | 0.06 |
Madurai | 22.3 | 14.4 | 0.59 (0.24-1.4) | 0.57 (0.23-1.4) | 0.23 |
Salem | 5.5 | 4.8 | 0.87 (0.29-2.6) | 0.56 (0.18-1.7) | 0.31 |
Syphilis prevalence (district wise) | Â | Â | Â | Â | Â |
Chennai | 12.9 | 9.9 | 0.74 (5.0-16.6) | 0.62 (0.3-1.4) | 0.24 |
Coimbatore | 14.5 | 6.3 | 0.39 (0.2-0.7) | 0.37 (0.2-0.8) | <0.01 |
Madurai | 17.8 | 6.6 | 0.34 (0.1-1.2) | 0.25 (0.1-0.9) | <0.05 |
Salem | 12.2 | 1.9 | 0.14 (0.1-0.4) | 0.08 (0.0-0.2) | <0.01 |
TGs | |||||
HIV-1 infection | 12 | 9.8 | 0.79 (0.4-1.6) | 1.3 (0.5-3.2) | 0.57 |
Reactive RPR + positive TPHA | 16.6 | 4.2 | 0.22(0.1-0.4) | 0.30 (0.1-0.7) | 0.01 |
Reactive RPR >1:8 + positive TPHA | 0 | 0 | - | - | - |
Chlamydia infection | 0 | 0 | - | -- | - |
Gonorrhoea infection | 0 | 0 | - | - | - |